DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

| Source: EQS Group AG EQS Group AG 

STADA Arzneimittel AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

12.03.2008 

Release of a Voting Rights announcement
---------------------------------------------------------------------------


On March 11, 2008, Marshall Wace LLP, ('Investment Manager'), London, Great
Britain, has informed us according to section 21, para. 1 WpHG that on
March 5, 2008 its voting rights on STADA Arzneimittel AG, Bad Vilbel,
Germany, ISIN: DE0007251803, have exceeded the threshold of 3% and hold
3,06% of the voting rights in the company (equivalent to 1,798,459 voting
rights) as of the aforementioned date.
The voting rights are to be ascribed to the Investment Manager pursuant to
section 22, para. 1, sentence 1, no. 6 WpHG.

DGAP 12.03.2008 
---------------------------------------------------------------------------
Language:     English
Issuer:       STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Deutschland
Internet:     www.stada.de
End of News                                     DGAP News-Service
---------------------------------------------------------------------------